These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
566 related articles for article (PubMed ID: 29210786)
21. Risk of Poor Neonatal Adaptation Syndrome Among Infants Exposed to Second-Generation Atypical Antipsychotics Compared to Antidepressants: Results From the National Pregnancy Registry for Psychiatric Medications. Viguera AC; McElheny SA; Caplin PS; Kobylski LA; Rossa ET; Young AV; Gaccione P; Góez-Mogollón L; Freeman MP; Cohen LS J Clin Psychiatry; 2023 Jan; 84(1):. PubMed ID: 36602927 [No Abstract] [Full Text] [Related]
22. Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting. Xiong GL; Jiang W; Clare RM; Shaw LK; Smith PK; O'Connor CM; Ranga K; Krishnan R; Kristin Newby L Clin Cardiol; 2010 Jun; 33(6):E94-8. PubMed ID: 20552618 [TBL] [Abstract][Full Text] [Related]
23. Effect of Abrupt Discontinuation of Antidepressants in Critically Ill Hospitalized Adults. Bainum TB; Fike DS; Mechelay D; Haase KK Pharmacotherapy; 2017 Oct; 37(10):1231-1240. PubMed ID: 28730691 [TBL] [Abstract][Full Text] [Related]
24. Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L-methylfolate as adjunctive therapy. Wade RL; Kindermann SL; Hou Q; Thase ME J Manag Care Pharm; 2014 Jan; 20(1):76-85. PubMed ID: 24372461 [TBL] [Abstract][Full Text] [Related]
25. Postpartum Psychiatric Outcomes and Sick Leave After Discontinuing SSRI or SNRI in Pregnancy. Cesta CE; Reutfors J; Cohen JM; Eriksson J; Furu K; Zoega H; Pazzagli L JAMA Netw Open; 2024 Oct; 7(10):e2438269. PubMed ID: 39378031 [TBL] [Abstract][Full Text] [Related]
26. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn. Bérard A; Sheehy O; Zhao JP; Vinet É; Bernatsky S; Abrahamowicz M Br J Clin Pharmacol; 2017 May; 83(5):1126-1133. PubMed ID: 27874994 [TBL] [Abstract][Full Text] [Related]
27. SSRI/SNRI Use is Not Associated with Increased Risk of Delayed Cerebral Ischemia After aSAH. Young JB; Singh TD; Rabinstein AA; Fugate JE Neurocrit Care; 2016 Apr; 24(2):197-201. PubMed ID: 26264066 [TBL] [Abstract][Full Text] [Related]
28. Discontinuation rates and health care costs in adult patients starting generic versus brand SSRI or SNRI antidepressants in commercial health plans. Vlahiotis A; Devine ST; Eichholz J; Kautzner A J Manag Care Pharm; 2011 Mar; 17(2):123-32. PubMed ID: 21348545 [TBL] [Abstract][Full Text] [Related]
29. Risk of abnormal uterine bleeding associated with high-affinity compared with low-affinity serotonin and norepinephrine reuptake inhibitors. Engler J; Filliter C; Montastruc F; Abenhaim H; Rej S; Renoux C J Affect Disord; 2024 Apr; 350():813-821. PubMed ID: 38246277 [TBL] [Abstract][Full Text] [Related]
30. Perioperative Selective Serotonin Reuptake Inhibitor Use Is Associated With an Increased Risk of Transfusion in Total Hip and Knee Arthroplasty. Belay ES; Penrose CT; Ryan SP; Bergen MA; Bolognesi MP; Seyler TM J Arthroplasty; 2019 Dec; 34(12):2898-2902. PubMed ID: 31477539 [TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of serotonin reuptake inhibitors (SSRI) and serotonin noradrenaline reuptake inhibitors (SNRI) for children and adolescents with anxiety disorders: a systematic review and meta-analysis. Stefánsdóttir ÍH; Ivarsson T; Skarphedinsson G Nord J Psychiatry; 2023 Feb; 77(2):137-146. PubMed ID: 35587815 [TBL] [Abstract][Full Text] [Related]
32. Perioperative use of selective serotonin reuptake inhibitors and risks for adverse outcomes of surgery. Auerbach AD; Vittinghoff E; Maselli J; Pekow PS; Young JQ; Lindenauer PK JAMA Intern Med; 2013 Jun; 173(12):1075-81. PubMed ID: 23699725 [TBL] [Abstract][Full Text] [Related]
33. Hyponatremia-associated hospital visits are not reduced by early electrolyte testing in older adults starting antidepressants. Lane NE; Bai L; Seitz DP; Juurlink DN; Paterson JM; Guan J; Stukel TA J Am Geriatr Soc; 2024 Jun; 72(6):1770-1780. PubMed ID: 38662854 [TBL] [Abstract][Full Text] [Related]
34. Question: How Should I Switch From One Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin and Norepinephrine Reuptake Inhibitor (SNRI) to Another SSRI or SNRI in a Patient With Major Depressive Disorder? Rothschild AJ J Clin Psychopharmacol; 2024 Sep-Oct 01; 44(5):531-532. PubMed ID: 39173041 [No Abstract] [Full Text] [Related]
35. Concomitant use of triptan, and SSRI or SNRI after the US Food and Drug Administration alert on serotonin syndrome. Sclar DA; Robison LM; Castillo LV; Schmidt JM; Bowen KA; Oganov AM; Skaer TL; Kogut SJ Headache; 2012 Feb; 52(2):198-203. PubMed ID: 22289074 [TBL] [Abstract][Full Text] [Related]
36. Association between warfarin combined with serotonin-modulating antidepressants and increased case fatality in primary intracerebral hemorrhage: a population-based study. Löppönen P; Tetri S; Juvela S; Huhtakangas J; Saloheimo P; Bode MK; Hillbom M J Neurosurg; 2014 Jun; 120(6):1358-63. PubMed ID: 24506245 [TBL] [Abstract][Full Text] [Related]
37. Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor Use as a Predictor of a Diagnosis of Restless Legs Syndrome. Bailey AL; Makela EH; Asberg K J Psychiatr Pract; 2016 Jul; 22(4):263-9. PubMed ID: 27427838 [TBL] [Abstract][Full Text] [Related]
38. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA. Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116 [TBL] [Abstract][Full Text] [Related]
39. Association of serotonin reuptake inhibitors with asthma control. Gajewski AJ; Palka JM; Raitt JM; Agarwal CD; Khan DA; Kao CH; Brown ES Allergy Asthma Proc; 2023 Sep; 44(5):354-360. PubMed ID: 37641216 [No Abstract] [Full Text] [Related]
40. Characteristics of patients with major depressive disorder switching SSRI/SNRI therapy compared with those augmenting with an atypical antipsychotic in a real-world setting. Kern DM; Cepeda MS; Castilla-Puentes RC; Savitz A; Etropolski M Curr Med Res Opin; 2021 Aug; 37(8):1377-1384. PubMed ID: 33818238 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]